Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer

Frontiers in Immunology(2020)10.3389/fimmu.2020.605619Source: DataRank Database

Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 45 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (52)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Adham S. Bear ORCID,Robert H. Vonderheide ORCID

Live enrichment

PubMed:33304355 PMC:PMC7693439

NCI NIH HHS

Grant: R01 CA229803

NCI NIH HHS

Grant: K12 CA076931

NCI NIH HHS

Grant: P30 CA016520

NCI NIH HHS

Grant: P01 CA210944

National Institutes of Health

Grant: 5P01CA210944-03

Radiation and checkpoint blockade for cancer immune therapy

National Institutes of Health

Grant: 5K12CA076931-24

Physician Scientist Training in Clinical Oncology

National Institutes of Health

Grant: 2P30CA016520-35

Abramson Cancer Center Support Grant

Parker Institute for Cancer Immunotherapy

National Institutes of Health

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.605619/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.605619/full

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7693439

repositoryhttps://doaj.org/article/df56915ac00e41c5a7e766fe1adef617

Europe_PMChttps://europepmc.org/articles/PMC7693439

Fields of Study

0301 basic medicine03 medical and health sciencesAnimalsCarcinoma, Pancreatic DuctalChemotaxis, LeukocyteCytokinesHumansImmunotherapyLymphocytes, Tumor-InfiltratingMyeloid-Derived Suppressor CellsPancreatic NeoplasmsSignal TransductionT-LymphocytesTumor EscapeTumor MicroenvironmentTumor-Associated Macrophages

MeSH Terms

T-LymphocytesLymphocytes, Tumor-InfiltratingAnimalsHumansCarcinoma, Pancreatic DuctalPancreatic NeoplasmsCytokinesImmunotherapySignal TransductionChemotaxis, LeukocyteTumor EscapeTumor MicroenvironmentMyeloid-Derived Suppressor CellsTumor-Associated Macrophages

Keywords

MacrophagesT cellsMyeloidPancreaticChemoattractant MoleculesMyeloid-Derived Suppressor CellsT-LymphocytesImmunologyRC581-607Pancreatic NeoplasmsChemotaxis, LeukocyteLymphocytes, Tumor-InfiltratingTumor-Associated MacrophagesTumor MicroenvironmentAnimalsCytokinesHumansTumor EscapeImmunotherapyImmunologic diseases. AllergyCarcinoma, Pancreatic DuctalSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good health

Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer

FAIR Checklist

Authors (2)

Funding (9 grants)

Open Access

Topics

Annotations (Europe PMC)